Table 2. Viscoelastic NATEM variables.
| Parameter | Group | Day 1 | Day 2 | Day 3 | Day 4 |
|---|---|---|---|---|---|
| CFT (sec) [Median (IQR)] | Control | 299 (198/654) | 408 (279/647) | 387 (271/591) | 328 (229/546) |
| IgM-IVIg | 238 (147/367) | 173 (125/286) | 201 (147/306) | 177 (143/276) | |
| CT (sec) [Median (IQR)] | Control | 900 (681/1084) | 1051 (847/1358) | 1046 (903/1082) | 953 (840/1137) |
| IgM-IVIg | 697 (552/981) | 724 (615/1185) | 839 (613/1218) | 788 (660/1334) | |
| α-angle (°) [Median (IQR)] | Control | 44 (27/55) | 34 (24/48) | 37 (27/47) | 46 (31/57) |
| IgM-IVIg | 58 (42/65) | 61 (48/67) | 57 (44/64) | 61 (50/65) | |
| MCF (mm) [Median (IQR)] | Control | 53 (41/67) | 54 (42/66) | 52 (42/62) | 47 (31/62) |
| IgM-IVIg | 63 (58/69) | 63 (58/69) | 67 (59/72) | 71 (63/75) |
CFT, clot formation time; CT, clotting time; MCF, mean clot firmness; IQR, interquartile range; IgM-IVIg, IgM enriched intravenous immunoglobulin; Control group n = 14, IgM-IVIg group n = 12 (days 1 and 2), n = 11 (day 3) and n = 10 (day 4); no significant differences between the groups